Related items

On Tuesday, 30 June, AmCham EU hosted a roundtable exploring strategies for preparing Europe’s workforce for the age of artificial intelligence (AI). Members and policymakers analysed how AI is changing roles across sectors and how employers, governments and education providers can respond. Joined by Idoia Mendia, MEP (ES, S&D) and Mario Nava, Director-General, Directorate-General for Employment, Social Affairs and Inclusion, European Commission, the conversation focused on digital and data skills, as well as expanding AI literacy across organisations. Participants also discussed reskilling and public-private cooperation to support a more inclusive labour market. In addition, members shared best practices from their companies and pointed to the need for policy frameworks that support lifelong learning and skills-based hiring. As AI becomes part of everyday work, Europe must close the skills gap to strengthen competitiveness and prepare people for the future of work.

The Carbon Border Adjustment Mechanism (CBAM) will test whether the EU can address carbon leakage while keeping investment in Europe. As implementation of the CBAM advances, companies face costs and reporting duties under rules that are still taking shape. Preventing carbon leakage matters. However, the CBAM should work in practice before scope extension is considered. Moving too soon could place burdens on companies and disrupt value chains, with consequences for investment and trade. The focus should be on avoiding measures that introduce further uncertainty and extending proposed safeguards in the Temporary Decarbonisation Fund beyond 2027. Learn how to shape the CBAM so it prevents carbon leakage while maintaining competitiveness. 

Pfizer selected Denmark as the site of the largest vaccine registry study ever undertaken, demonstrating how Europe can attract world-leading life sciences investment when the right conditions are in place. Beginning in 2024, Pfizer partnered with researchers at the Center for Translational Cardiology and Pragmatic Randomized Trials at Herlev-Gentofte Hospital in Copenhagen to assess whether its respiratory syncytial virus vaccine could reduce hospitalisations in adults. Denmark’s innovation-friendly environment, national digital mailbox eBoks and world-class health registries enabled researchers to invite almost the entire adult population to take part, helping recruit more than 500,000 participants. Study materials were made available online, allowing participants to provide informed consent from home, while health registries supported comprehensive tracking and analysis. This milestone shows how strong public-private collaboration and a supportive policy framework can help Europe deliver clinical research at scale and improve health outcomes for citizens. Read the full story on Invested in Europe.